| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/17/2012 | US20120121570 Test for Predicting Neutralization of Asparaginase Activity |
| 05/17/2012 | US20120121569 Methods of treating infections originating from viruses in the herpesviridae family |
| 05/17/2012 | US20120121568 Superoxide dismutase variants and methods of use thereof |
| 05/17/2012 | US20120121566 Solubilized CoQ-10 |
| 05/17/2012 | US20120121557 Neuregulin induced proliferation of cardiomyocytes |
| 05/17/2012 | US20120121556 Methods of using regenerative cells to promote wound healing |
| 05/17/2012 | US20120121555 Compositions and Methods of Using Living and Non-Living Bioactive Devices with Components Derived From Self-Renewing Colony Forming Cells Cultured and Expanded In Vitro |
| 05/17/2012 | US20120121543 Anti-microbial agent from paenibacillus sp. and methods and uses thereof |
| 05/17/2012 | US20120121542 Red-shifted opsin molecules and uses thereof |
| 05/17/2012 | US20120121541 3,5-disubstituted and 3,5,7-trisubstituted-3h-oxazolo and 3h-thiazolo[4,5-d]pyrimidin-2-one compounds and prodrugs thereof |
| 05/17/2012 | US20120121540 Certain Nitrogen Containing Bicyclic Chemical Entities For Treating Viral Infections |
| 05/17/2012 | US20120121539 Programming Of Cells for Tolerogenic Therapies |
| 05/17/2012 | US20120121538 Combined measles-malaria vaccine |
| 05/17/2012 | US20120121537 Methods and Compositions for Inhibiting Hepatitis C Virus Replication |
| 05/17/2012 | US20120121536 Compositions and methods for glucose transport inhibition |
| 05/17/2012 | US20120121535 Agent for preventing recurrence of leukemia |
| 05/17/2012 | US20120121532 Process for making dry and stable hemostatic compositions |
| 05/17/2012 | US20120121530 Vasoprotective and cardioprotective antidiabetic therapy |
| 05/16/2012 | EP2453024A2 Genes and pathways differentially expressed in bipolar disorder and/or major depressive disorder |
| 05/16/2012 | EP2453018A1 A herbicide metabolizing protein, a gene thereof and use thereof |
| 05/16/2012 | EP2453009A1 Methods of organ regeneration |
| 05/16/2012 | EP2452949A1 Use of carbonic anhydrase ii for producing a drug |
| 05/16/2012 | EP2452698A2 Novel method for treatment of skin wounds and preparations for implementation of same |
| 05/16/2012 | EP2452692A1 Treatment of autoimmune disorders with a neurotoxin |
| 05/16/2012 | EP2452691A2 Methods and compositions for prevention of diabetic and aged skin |
| 05/16/2012 | EP2452688A1 Use of interleukine 10 RNA transfected macrophages in anti-inflammatory therapies |
| 05/16/2012 | EP2452687A2 Methods and compositions for prevention and treatment of diabetic and aged skin |
| 05/16/2012 | EP2452686A2 Methods and compositions for prevention and treatment of diabetic and aged skin |
| 05/16/2012 | EP2452683A2 Methods for treating atherosclerosis |
| 05/16/2012 | EP2452675A1 Buccal spray containing sildenafil |
| 05/16/2012 | EP2452672A2 Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections |
| 05/16/2012 | EP2452653A1 cRGD peptide derivative and its manufacture and implant having a coating containing a cRGD peptide derivative |
| 05/16/2012 | EP2451835A1 Variants of plasminogen and plasmin |
| 05/16/2012 | EP2451834A1 Methods related to a mutation in complement factor h-related protein 5 in patients with glomerulonephritis |
| 05/16/2012 | EP2451474A1 Codon-optimized factor vi i i variants and synthetic liver-specific promoter |
| 05/16/2012 | EP2451473A2 Long-acting coagulation factors and methods of producing same |
| 05/16/2012 | EP2451472A1 Heat- and vibration-stable insulin preparations |
| 05/16/2012 | EP2451471A1 Slow-acting insulin preparations |
| 05/16/2012 | EP2451470A1 METHOD FOR THE PURIFICATION OF INTERFERON-ß |
| 05/16/2012 | EP2451469A2 Composition for the treatment of benign prostate hyperplasia |
| 05/16/2012 | EP2451454A1 Method of treating age related disorders |
| 05/16/2012 | EP2451449A1 Use of the combination of teriflunomide and interferon beta for treating multiple sclerosis |
| 05/16/2012 | EP2451439A1 Composition comprising bioactive amino acids and/or peptides and marine oil in a stable oil-in-water emulsion, and the use of said composition as a functional or therapeutic composition |
| 05/16/2012 | EP2451436A1 Method and pharmaceutical compositions for trans-buccal mucosa treatment of postprandial hyperglycaemia in type ii diabetes |
| 05/16/2012 | EP2331114B1 Fc gamma receptor for the treatment of b cell mediated multiple sclerosis |
| 05/16/2012 | EP2224945B1 Methods of enhancing diabetes resolution |
| 05/16/2012 | EP2135951B1 Method of preparing human NGF Beta protein |
| 05/16/2012 | CN1950397B Therapeutic use of a growth factor, NsG33 |
| 05/16/2012 | CN1575338B Bv8 nucleic acids and polypeptides with mitogenic activity |
| 05/16/2012 | CN102460175A STRUCTURE OF THE C-TERMINAL REGION OF THE INSULIN RECEPTOR a-CHAIN AND OF THE INSULIN-LIKE GROWTH FACTOR RECEPTOR a-CHAIN |
| 05/16/2012 | CN102459651A Method of determining response to treatment with immunomodulatory composition |
| 05/16/2012 | CN102459602A Neuron generation, regeneration and protection |
| 05/16/2012 | CN102459576A Compositions and methods for modulating stem cells and uses thereof |
| 05/16/2012 | CN102459348A 用于将gdnf和bdnf递送至中枢神经系统的融合蛋白 Fusion protein is used to gdnf and bdnf delivered to the central nervous system |
| 05/16/2012 | CN102459328A 制备低铁乳铁蛋白的方法 The method of preparation of low iron lactoferrin |
| 05/16/2012 | CN102459327A Improved reconstituted surfactant composition containing analogs of surfactant protein b (sp-b) and surfactant protein c (sp-c) |
| 05/16/2012 | CN102459321A 酪蛋白来源的蛋白酶抑制肽 Casein-derived protease inhibitory peptide |
| 05/16/2012 | CN102459314A Ttk peptides and vaccines including the same |
| 05/16/2012 | CN102459313A High penetration prodrug compositions of peptides and peptide-related compounds |
| 05/16/2012 | CN102459312A Melanocortin receptor-specific peptides |
| 05/16/2012 | CN102459311A 神经调节肽u衍生物 Neuromedin derivative u |
| 05/16/2012 | CN102459310A Cosmetic and/or pharmaceutical composition comprising a peptidic hydrolysate that can reinforce the barrier function |
| 05/16/2012 | CN102458476A 用于治疗多发性硬化症的组合物及方法 Treatment of multiple sclerosis compositions and methods for |
| 05/16/2012 | CN102458472A Pharmaceutical composition, food or beverage, and methods for these products |
| 05/16/2012 | CN102458470A Alpha thymosin peptides as vaccine enhancers |
| 05/16/2012 | CN102458458A Combination immunotherapy compositions against cancer and methods |
| 05/16/2012 | CN102458455A 因子vii组合物 Factor vii composition |
| 05/16/2012 | CN102458454A 用于治疗亨廷顿病的组织激肽释放酶 Tissue bradykinin release for the treatment of Huntington's disease enzyme |
| 05/16/2012 | CN102458453A 用于治疗精神分裂症和双相型障碍的组织激肽释放酶 Tissue for the treatment of schizophrenia and bipolar disorder kallikrein |
| 05/16/2012 | CN102458452A Antimicrobial agents |
| 05/16/2012 | CN102458451A 血红蛋白组合物 Hemoglobin composition |
| 05/16/2012 | CN102458450A Lactoferrin and brain health and development in infants |
| 05/16/2012 | CN102458449A Combination of (a) a phosphoinositide 3-kinase inhibitor and (b) an antidiabetic compound for use in the treatment of proliferative diseases |
| 05/16/2012 | CN102458448A Lactoferrin and brain health and protection in adults |
| 05/16/2012 | CN102458447A Reference picture lists for 3dv |
| 05/16/2012 | CN102458446A Compositions for use in the treatment of chronic obstructive pulmonary diseases and asthma |
| 05/16/2012 | CN102458445A Fviii衍生肽 Fviii derived peptides |
| 05/16/2012 | CN102458444A 用作丙型肝炎病毒抑制剂的大环化合物 Hepatitis C virus inhibitors used as macrocycles |
| 05/16/2012 | CN102458443A 细胞周期蛋白依赖性激酶抑制剂及使用方法 Cyclin-dependent kinase inhibitors and methods of use |
| 05/16/2012 | CN102458442A 具有受控血清药代动力学的人蛋白支架 Human protein scaffold with controlled serum pharmacokinetics |
| 05/16/2012 | CN102458441A 用于治疗神经疾病的模型系统和治疗方案 For the treatment of neurological disease model systems and treatment regimens |
| 05/16/2012 | CN102458440A Papillomavirus-like particles (vlp) as broad spectrum human papillomavirus (hpv) vaccines |
| 05/16/2012 | CN102458439A 包含抗真菌肽的药物组合物 Pharmaceutical composition comprising an antifungal peptide |
| 05/16/2012 | CN102458438A 具有肽骨架和c-末端修饰的经修饰补体抑素 Somatostatin has modified the peptide backbone complement and c- terminal modification of |
| 05/16/2012 | CN102458437A Anti-il-17f antibodies and methods of use thereof |
| 05/16/2012 | CN102458436A Melanocortin receptor-specific peptides |
| 05/16/2012 | CN102458427A Combined measles-malaria vaccine |
| 05/16/2012 | CN102458416A Interlaced method for treating cancer or a precancerous condition |
| 05/16/2012 | CN102458400A Serotonin 5-ht3 receptor antagonists for use in the treatment of lesional vestibular disorders |
| 05/16/2012 | CN102453097A Angiogenesis inhibiting fusion protein VF and pharmaceutical composition and application thereof |
| 05/16/2012 | CN102453095A Fusion protein containing GLP (glucagon-like peptide)-1 and preparation method and application thereof |
| 05/16/2012 | CN102453094A Fusion protein containing Exendin-4 and preparation method and application thereof |
| 05/16/2012 | CN102453089A Preparation and application of recombinant consensus interferon mutant polyethylene glycol conjugate |
| 05/16/2012 | CN102453088A Anti-chicken infectious bursal disease specific transfer factor and preparation method thereof |
| 05/16/2012 | CN102453086A Natural immunomodulation protein TRIM38 and its purpose |
| 05/16/2012 | CN102453080A Modified small peptide and application thereof |
| 05/16/2012 | CN102453079A Peptide specifically binding basic fibroblast growth factor receptor |
| 05/16/2012 | CN102453077A Novel fluoronosiheptide and preparation method and application thereof |
| 05/16/2012 | CN102451472A Application of minimal heterodimer partner in blood lipid regulation |
| 05/16/2012 | CN102451471A Polyethyleneglycol-staphylokinase conjugate as well as preparing method and application thereof |